AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Dayglim M 0.5mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Daylon Healthcare

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Dayglim M 0.5mg/500mg Tablet ER

Metformin/Glimepiride extended-release tablets (0.5mg/500mg) are classified as antidiabetic agents. This dual-medication formulation manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision may lead to elevated blood sugar, increasing the risk of complications including renal impairment, vision loss, neuropathy, and limb amputation. This medication is one component of a comprehensive diabetes management plan, which should also incorporate a balanced diet, regular physical activity, and weight management as directed by your healthcare provider. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to identify its symptoms—sweating, lightheadedness, headache, trembling—and appropriate countermeasures. Maintain regular mealtimes and carry a readily available fast-acting glucose source (e.g., sugary snacks, fruit juice). Alcohol consumption elevates hypoglycemia risk and should be avoided. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your physician before commencing treatment, as this medication may be unsuitable. Pregnant or lactating women should seek medical counsel prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Dayglim M 0.5mg/500mg Tablet ER

No text was provided to rewrite.

Uses of Dayglim M 0.5mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Dayglim M 0.5mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Dayglim M 0.5mg/500mg Extended-Release tablet whole; do not alter its form by chewing, crushing, or breaking. Consume this medication with a meal.

Common Side effects of Dayglim M 0.5mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Dayglim M 0.5mg/500mg Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. Dayglim M 0.5mg/500mg Extended-Release tablets should be taken with a meal.

How Dayglim M 0.5mg/500mg Tablet ER works:

Dayglim M 0.5mg/500mg Extended-Release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Dayglim M 0.5mg/500mg extended-release tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Dayglim M 0.5mg/500mg tablet might pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Dayglim M 0.5mg/500mg tablets are contraindicated during lactation. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Dayglim M 0.5mg/500mg Extended-Release tablets, as dosage modification may be necessary. A physician's consultation is recommended. Dayglim M 0.5mg/500mg Extended-Release tablets are contraindicated in individuals with severe kidney disease. Close monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Dayglim M 0.5mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. In individuals with mild to moderate hepatic dysfunction, initiation should be at a low dose; the medication is contraindicated in those with severe liver disease.

What if you forget to take Dayglim M 0.5mg/500mg Tablet ER :

Should you forget a Dayglim M 0.5mg/500mg Extended-Release tablet, take it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Dayglim M 0.5mg/500mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Dayglim M 0.5mg/500mg Tablet ER

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Dayglim M 0.5mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Dayglim M 0.5mg/500mg Tablet ER and seek immediate medical attention.
Dayglim M 0.5mg/500mg Extended-Release tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Dayglim M 0.5mg/500mg Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged use of Dayglim M 0.5mg/500mg Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Dayglim M 0.5mg/500mg Tablet ER can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Dayglim M 0.5mg/500mg ER tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Dayglim M 0.5mg/500mg Tab...
56
MRP 65
13% off